Bio-Rad Laboratories (NYSE: BIO and BIOb) offers a broad range of innovative tools and services to the life science research and clinical diagnostics markets. Founded in 1952, Bio-Rad has a global team of more than 7,600 employees and serves more than 100,000 research and industry customers worldwide through the company's global network of operations. Throughout its existence, Bio-Rad has built strong customer relationships that advance scientific research and development efforts and support the introduction of new technology used in the growing fields of genomics, proteomics, drug discovery, food safety, medical diagnostics, and more. Based in Hercules, CA, Bio-Rad has operations worldwide.
Company Growth (employees)
Type
Public
HQ
Hercules, US
Founded
1952
Size (employees)
8,250 (est)+7%
Bio-Rad was founded in 1952 and is headquartered in Hercules, US

Bio-Rad Office Locations

Bio-Rad has an office in Hercules
Hercules, US (HQ)
1000 Alfred Nobel Dr

Bio-Rad Data and Metrics

Bio-Rad Financial Metrics

Bio-Rad's revenue was reported to be $2.1 b in 2016
Numbers are in $, USD

Revenue (Y, 2016)

2.1 b

Revenue growth (Y, 2015 - Y, 2016), %

2%

Gross profit (Y, 2016)

1.1 b

Gross profit margin (Y, 2016), %

55%

EBIT (Y, 2016)

53.2 m

Market capitalization (24-May-2017)

6.5 b

Closing share price (24-May-2017)

219.4

Cash (31-Dec-2016)

456.3 m
Bio-Rad's current market capitalization is $6.5 b.
Numbers are in $, USDFY, 2013FY, 2014FY, 2015Y, 2016

Revenue

2.1 b2.2 b2 b2.1 b

Revenue growth, %

2%(7%)2%

Cost of goods sold

897.8 m930.1 m

Gross profit

1.1 b1.1 b

Gross profit Margin, %

56%55%

EBIT

166.7 m53.2 m

EBIT margin, %

8%3%

Pre tax profit

145.8 m41.6 m

Net Income

77.8 m88.8 m113.1 m
Numbers are in $, USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

331.6 m413.3 m457.5 m456.3 m

Accounts Receivable

Inventories

Current Assets

1.7 b1.7 b1.8 b1.8 b

PP&E

429.4 m428.8 m437.7 m488.6 m

Total Assets

3.4 b3.3 b3.7 b3.9 b

Accounts Payable

148.5 m128.6 m122.4 m133.1 m

Current Liabilities

487.5 m446.8 m441.4 m471.3 m

Common Stock

2 k2 k2 k2 k

Preferred Stock

Additional Paid-in Capital

240 m271.3 m300.4 m332.9 m

Retained Earnings

1.6 b1.7 b1.8 b1.8 b

Total Equity

2.2 b2.2 b2.5 b2.6 b

Financial Leverage

1.5 x1.5 x1.5 x1.5 x
Numbers are in $, USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

77.8 m88.8 m113.1 m

Accounts Receivable

Inventories

Accounts Payable

Cash From Operating Activities

175.5 m273.3 m186.2 m216.4 m

Capital Expenditures

(113 m)(121 m)(112 m)(141.4 m)

Cash From Investing Activities

(5.4 m)(190.5 m)(166.9 m)(213.9 m)

Cash From Financing Activities

(311.7 m)11.7 m8.6 m9 m

Interest Paid

(61.2 m)(20.8 m)(20.8 m)(21.3 m)

Free Cash Flow

288.5 m394.3 m298.2 m357.9 m
Y, 2016

Financial Leverage

1.5 x

Bio-Rad Market Value History

Bio-Rad Online and Social Media Presence

Bio-Rad News and Updates

Bio-Rad Company Life and Culture

You may also be interested in